Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Management of severe peri-operative bleeding

Management of severe peri-operative bleeding Eur J Anaesthesiol 2023; 40:223–225 EDITORIAL A call for action by the ESAIC Donat R. Spahn and Alexander Kaserer European Journal of Anaesthesiology 2023, 40:223–225 with an increased peri-operative bleeding risk (e.g., due to underlying coagulation disorders, or anticoagulant or platelet inhibitor drugs) so that appropriate preventive measures can be instituted pre-operatively. Conventional 1–3 Peri-operative blood loss and also the transfusion of coagulation tests (e.g., prothrombin time, activated pro- 1,2,4 5 6 red blood cell (RBC), plasma, and platelets are thrombin time, etc.) are not reliable predictors of the peri- 1,2,7 8 associated with adverse outcomes and high costs. operative bleeding risk, and normal results give the Although, in a considerable percentage of individual 11 physician a false sense of security. Although still regu- surgical procedures it is the surgical technique itself larly performed, routine coagulation tests are therefore that results in the increased surgical blood loss, anaes- not recommended. Instead, a standardised coagulation thesiologists are generally required to solve the problem. questionnaire is more powerful to detect an underlying The European Society of Anaesthesiology and Intensive 12,13 coagulation disorder if it is suspected clinically. Care (ESAIC) therefore has created guidelines on the Which patients should be optimised, and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Anaesthesiology Wolters Kluwer Health

Management of severe peri-operative bleeding

Download PDF
3 pages

Loading next page...
 
/lp/wolters-kluwer-health/management-of-severe-peri-operative-bleeding-Urz22zUEcs

References (31)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.
ISSN
0265-0215
eISSN
1365-2346
DOI
10.1097/eja.0000000000001804
Publisher site
See Article on Publisher Site

Abstract

Eur J Anaesthesiol 2023; 40:223–225 EDITORIAL A call for action by the ESAIC Donat R. Spahn and Alexander Kaserer European Journal of Anaesthesiology 2023, 40:223–225 with an increased peri-operative bleeding risk (e.g., due to underlying coagulation disorders, or anticoagulant or platelet inhibitor drugs) so that appropriate preventive measures can be instituted pre-operatively. Conventional 1–3 Peri-operative blood loss and also the transfusion of coagulation tests (e.g., prothrombin time, activated pro- 1,2,4 5 6 red blood cell (RBC), plasma, and platelets are thrombin time, etc.) are not reliable predictors of the peri- 1,2,7 8 associated with adverse outcomes and high costs. operative bleeding risk, and normal results give the Although, in a considerable percentage of individual 11 physician a false sense of security. Although still regu- surgical procedures it is the surgical technique itself larly performed, routine coagulation tests are therefore that results in the increased surgical blood loss, anaes- not recommended. Instead, a standardised coagulation thesiologists are generally required to solve the problem. questionnaire is more powerful to detect an underlying The European Society of Anaesthesiology and Intensive 12,13 coagulation disorder if it is suspected clinically. Care (ESAIC) therefore has created guidelines on the Which patients should be optimised, and

Journal

European Journal of Anaesthesiology – Wolters Kluwer Health

Published: Apr 1, 2023

There are no references for this article.